Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masataka Okamoto

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Internal Medicine (Tokyo, Japan)|October 2, 2008
Chronic myeloid leukemia following chemotherapy with 5'-deoxy-5-fluorouridine for gastric cancerMotohiro Tsuzuki, Kousuke Handa, Kiyoko Yamamoto, et al.
Genes, Chromosomes & Cancer|November 16, 2004
Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survivalTomoko Yoshioka, Ikuo Miura, Masaaki Kume, et al.
Blood|September 21, 2006
Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5Takuhei Murase, Motoko Yamaguchi, Ritsuro Suzuki, et al.
Hematology (Amsterdam, Netherlands)|January 17, 2013
Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experienceAkinao Okamoto, Masamitsu Yanada, Yoko Inaguma, et al.
Oncology|September 30, 2016
Influence of R-CHOP Therapy on Immune System Restoration in Patients with B-Cell LymphomaKaori Ito, Masataka Okamoto, Yoko Inaguma, et al.
International Journal of Hematology|January 20, 2016
TP53 mutations in older adults with acute myeloid leukemiaMasamitsu Yanada, Yukiya Yamamoto, Sachiko Iba, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 21, 2010
[Alteration in antibody-mediated immunity in patients with rituximab-combined chemotherapy and incidence of herpes zoster]Kaori Ito, Masataka Okamoto, Fumio Maruyama, et al.
The Journal of Pathology|December 15, 2005
Immunoglobulin VH genes in thymic MALT lymphoma are biased toward a restricted repertoire and are frequently unmutatedMegumi Yoshida, Mitsukuni Okabe, Tadaaki Eimoto, et al.
Cancer Research|September 3, 2004
Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative casesHiroyuki Tagawa, Shinobu Tsuzuki, Ritsuro Suzuki, et al.
International Journal of Clinical Oncology|March 28, 2016
Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinolKazuo Tamura, Yasukazu Kawai, Toru Kiguchi, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Internal Medicine (Tokyo, Japan)|October 2, 2008
Chronic myeloid leukemia following chemotherapy with 5'-deoxy-5-fluorouridine for gastric cancerMotohiro Tsuzuki, Kousuke Handa, Kiyoko Yamamoto, et al.
Genes, Chromosomes & Cancer|November 16, 2004
Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survivalTomoko Yoshioka, Ikuo Miura, Masaaki Kume, et al.
Blood|September 21, 2006
Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5Takuhei Murase, Motoko Yamaguchi, Ritsuro Suzuki, et al.
Hematology (Amsterdam, Netherlands)|January 17, 2013
Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experienceAkinao Okamoto, Masamitsu Yanada, Yoko Inaguma, et al.
Oncology|September 30, 2016
Influence of R-CHOP Therapy on Immune System Restoration in Patients with B-Cell LymphomaKaori Ito, Masataka Okamoto, Yoko Inaguma, et al.
International Journal of Hematology|January 20, 2016
TP53 mutations in older adults with acute myeloid leukemiaMasamitsu Yanada, Yukiya Yamamoto, Sachiko Iba, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 21, 2010
[Alteration in antibody-mediated immunity in patients with rituximab-combined chemotherapy and incidence of herpes zoster]Kaori Ito, Masataka Okamoto, Fumio Maruyama, et al.
The Journal of Pathology|December 15, 2005
Immunoglobulin VH genes in thymic MALT lymphoma are biased toward a restricted repertoire and are frequently unmutatedMegumi Yoshida, Mitsukuni Okabe, Tadaaki Eimoto, et al.
Cancer Research|September 3, 2004
Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative casesHiroyuki Tagawa, Shinobu Tsuzuki, Ritsuro Suzuki, et al.
International Journal of Clinical Oncology|March 28, 2016
Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinolKazuo Tamura, Yasukazu Kawai, Toru Kiguchi, et al.
Pageof 7